CannaRoyalty (ORHOF) Stock Price, News & Analysis

Company Overview

CannaRoyalty Corp. is a specialty investment firm focused exclusively on the legal cannabis industry. Headquartered in Vancouver, British Columbia, the company deploys capital into a diversified portfolio of cultivation, processing and consumer-facing assets. CannaRoyalty’s underlying strategy centers on acquiring equity stakes and royalty interests in best-in-class operators and brands, with the goal of generating stable, long-term revenue streams as global markets mature.

The firm’s primary business activities include private equity investments, royalty and stream financing, and consulting services for licensing, product development and regulatory compliance. CannaRoyalty works closely with management teams to develop cultivation facilities, streamline extraction processes and build consumer product lines. Through royalty agreements, the company earns a percentage of gross revenues from partners’ cannabis sales, providing downside protection in emerging jurisdictions.

Founded in 2016 by industry veteran Greg McLeish, CannaRoyalty completed its initial public listing in 2017. Under McLeish’s leadership—supported by a management team experienced in finance, production and research—the company has executed investments across North America and pursued selective opportunities in Europe and Latin America. During its growth phase, CannaRoyalty has established strategic partnerships with both public and private operators to capitalize on new licensing regimes and consumer trends.

Today, CannaRoyalty maintains a geographically diversified footprint and a flexible capital deployment model. By combining royalty financing with equity stakes and hands-on advisory services, the firm aims to create value across the cannabis supply chain—from seed genetics and cultivation to branded product manufacturing and distribution.

Key Stats

• Today's Range: $9.23 to $9.23
• 50-Day Range: $9.23 to $9.23
• 52-Week Range: $2.60 to $9.75
• Volume: 500 shs
• Average Volume: 187,800 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:ORHOF
• CIK: N/A
• Web: www.originhouse.com
• Phone: 613-680-5070
• Fax: N/A
• Employees: 20
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A